Literature DB >> 21830939

Redirecting T cells.

Walter J Urba, Dan L Longo.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21830939     DOI： 10.1056/NEJMe1106965

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  A pharmacologic perspective on newly emerging T-cell manipulation technologies.

Authors:  Dominic Smethurst
Journal:  Br J Clin Pharmacol       Date:  2013-08       Impact factor: 4.335

Review 2.  Novel AIDS therapies based on gene editing.

Authors:  Kamel Khalili; Martyn K White; Jeffrey M Jacobson
Journal:  Cell Mol Life Sci       Date:  2017-02-16       Impact factor: 9.261

Review 3.  Immune reconstitution in chronic lymphocytic leukemia.

Authors:  John C Riches; Alan G Ramsay; John G Gribben
Journal:  Curr Hematol Malig Rep       Date:  2012-03       Impact factor: 3.952

4.  Immunotherapy targets in pediatric cancer.

Authors:  Rimas J Orentas; Daniel W Lee; Crystal Mackall
Journal:  Front Oncol       Date:  2012-01-30       Impact factor: 6.244

5.  Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation.

Authors:  Marvin M van Luijn; Martine E D Chamuleau; Gert J Ossenkoppele; Arjan A van de Loosdrecht; S Marieke van Ham
Journal:  Oncoimmunology       Date:  2012-03-01       Impact factor: 8.110

Review 6.  Genetically enhanced T lymphocytes and the intensive care unit.

Authors:  Tiberiu Tat; Huming Li; Catalin-Sorin Constantinescu; Anca Onaciu; Sergiu Chira; Ciprian Osan; Sergiu Pasca; Bobe Petrushev; Vlad Moisoiu; Wilhelm-Thomas Micu; Cristian Berce; Sebastian Tranca; Delia Dima; Ioana Berindan-Neagoe; Jianliang Shen; Ciprian Tomuleasa; Liren Qian
Journal:  Oncotarget       Date:  2018-03-27

Review 7.  Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia.

Authors:  Ciprian Tomuleasa; Shigeo Fuji; Cristian Berce; Anca Onaciu; Sergiu Chira; Bobe Petrushev; Wilhelm-Thomas Micu; Vlad Moisoiu; Ciprian Osan; Catalin Constantinescu; Sergiu Pasca; Ancuta Jurj; Laura Pop; Ioana Berindan-Neagoe; Delia Dima; Shigehisa Kitano
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561

Review 8.  Tailoring the Treatment of Melanoma: Implications for Personalized Medicine.

Authors:  Linna Duan; Eric M Mukherjee; Deepak Narayan
Journal:  Yale J Biol Med       Date:  2015-11-24

9.  Biosimilar Gene Therapy: Investigational Assessment of Secukinumab Gene Therapy.

Authors:  Ali Fallah; Hajar Estiri; Elizabeth Parrish; Mansoureh Soleimani; Sirous Zeinali; Azita Zadeh-Vakili
Journal:  Cell J       Date:  2019-07-29       Impact factor: 2.479
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.